Clinical Trial Update: An Open Label Trial of TMS Therapy for Bipolar Depression [NA]

View source ↗

Summary

An open-label clinical trial evaluating transcranial magnetic stimulation (TMS) therapy for bipolar depression has completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Bipolar Disorder

Drugs mentioned

• TMS therapy

Snippet

Sponsor: Sheppard Pratt Health System | Conditions: Bipolar Depression | NA | Status: COMPLETED | Results posted: 2022-05-12